Patents by Inventor Mélanie ETHEVE-QUELQUEJEU

Mélanie ETHEVE-QUELQUEJEU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210300926
    Abstract: The present invention relates to a compound of the following formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, notably for use as ?-lactamase inhibitors, notably in the treatment of a disease caused by gram negative bacteria, in particular enterobacteria, as well as pharmaceutical compositions containing such a compound and a process to prepare such a compound.
    Type: Application
    Filed: December 21, 2018
    Publication date: September 30, 2021
    Inventors: Jean-Luc MAINARDI, Michel ARTHUR, Mélanie ETHEVE-QUELQUEJEU, Laura IANNAZZO
  • Publication number: 20200325139
    Abstract: The present invention relates to a compound of the folowing formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, notably for use as a dmg, notably in the treatment of a disease caused by mycobacteria, as well as pharmaceutical compositions containing such a compound and a process to prepare such a compound.
    Type: Application
    Filed: December 21, 2018
    Publication date: October 15, 2020
    Inventors: Jean-Luc MAINARDI, Michel ARTHUR, Mélanie ETHEVE-QUELQUEJEU, Laura IANNAZZO
  • Patent number: 9181294
    Abstract: The present invention describes the use of nucleoside analogs for the treatment of viral infections, in particular of an HIV infection, and also compositions comprising at least one of these analogs, and a method for evaluating the sensitivity to said treatment.
    Type: Grant
    Filed: October 23, 2012
    Date of Patent: November 10, 2015
    Assignee: Universite Pierre Et Marie Curie (Paris 6)
    Inventors: Vincent Calvez, Anne-Genevieve Marcelin, Cathia Soulie, Melanie Etheve-Quelquejeu, Matthieu Sollogoub